CJC-1295 No DAC

A GHRH analogue that stimulates GHRH receptors to amplify the GH pulse when combined with a secretagogue like Ipamorelin. Designed specifically to be stacked.

Binds pituitary GHRH receptors to increase the amplitude of endogenous growth hormone pulses, complementing ghrelin-receptor secretagogues.

Think of Ipamorelin as pressing the GH release button and CJC-1295 No DAC as amplifying how loud that button sounds. Together they produce a natural GH pulse significantly larger than either alone.

• GH pulse amplitude
• IGF-1 response
• Body composition change
• Recovery and sleep quality markers

• GH pulse amplification
• Body composition in stacked protocols
• Recovery and sleep quality
• IGF-1 elevation

Derived from the first 29 amino acids of endogenous GHRH, modified for stability without the Drug Affinity Complex used in the long-acting variant.

Men and women 30-65 seeking GH optimisation, typically as part of an Ipamorelin stack.

• Reconstitute with bacteriostatic water.
• Add diluent slowly down the vial wall and swirl.
• Very short half-life, timing is critical.
• Store lyophilised at -20C, reconstituted at 4C.
• Protect from light and avoid shaking.

• Designed for stacking rather than standalone use.
• Short half-life produces a sharp pulse, not sustained elevation.
• Distinct from the DAC variant in protocol design.
• Works upstream of pituitary GH release.